Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
CIMA — Centro de Información de Medicamentos · Spain
- Updated
- Not provided for this source record
- Synchronized
- Oct 2, 2026
Medicine · Spain
CINFATUSINA 3,54 mg/ml SUSPENSIÓN ORAL
Suspension
Home Med Cabinet
Updated · Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) — Not provided for this source record
Synchronized
At a glance
- Active ingredient
- CLOPERASTINA FENDIZOATO — 3.54 mg
- Pharmaceutical form Home Med Cabinet grouping
- Suspension
- Availability in Spain
- All 2 packs marketed
Packs
CINFATUSINA 3,54 mg/ml SUSPENSIÓN ORAL, 1 frasco de 200 ml (vidrio)
200 ml
National code
Marketed672418Strength of this pack 3.54 mg
CINFATUSINA 3,54 mg/ml SUSPENSIÓN ORAL, 1 frasco de 120 ml (vidrio)
120 ml
National code
Marketed672419Strength of this pack 3.54 mg
“Marketed” means the authority records the pack as placed on the market. It is not a statement about pharmacy stock.
Official documents
Documents open on the authority’s own site. Home Med Cabinet links to them and hosts no copy.
- Official
Opens on the authority’s own site
- Official
Summary of product characteristics
Opens on the authority’s own site
Registration
- Registration number
- 72690Official data
- Marketing authorisation holder
- LABORATORIOS CINFA S.A.Official data
- Authorised
- Sep 2, 2010Official data
- Authority form code
- 6Official data
Classification
ATC classification is not published here yet
Publication rights for ATC codes and labels are still under review, and no classification is inferred for this record.